IPP Bureau

Lupin launches Atharv ability neuro-rehabilitation centre in Delhi
Lupin launches Atharv ability neuro-rehabilitation centre in Delhi

By IPP Bureau - May 18, 2026

New Delhi facility expands Lupin’s specialized neuro-rehabilitation network after Mumbai and Hyderabad launches

Alembic Pharma Q4 revenue rises to Rs. 1,848 crore
Alembic Pharma Q4 revenue rises to Rs. 1,848 crore

By IPP Bureau - May 18, 2026

US formulations grew 11% to Rs. 564 crore as Alembic enters US branded pharmaceuticals market with launch of Pivya

Amrutanjan Healthcare expands portfolio in pain management
Amrutanjan Healthcare expands portfolio in pain management

By IPP Bureau - May 18, 2026

Company enters women’s personal grooming segment while strengthening pain management portfolio with herbal Ortho Oil

Akums Q4 revenue climbs to Rs. 1,158 crore; PAT surges 135%
Akums Q4 revenue climbs to Rs. 1,158 crore; PAT surges 135%

By IPP Bureau - May 18, 2026

FY26 revenue rises to Rs. 4,359 crore as India’s leading CDMO strengthens global footprint with EU GMP certifications, UK MHRA approval and Europe supplies

Caplin Steriles receives USFDA approval for generic foscarnet sodium injection
Caplin Steriles receives USFDA approval for generic foscarnet sodium injection

By IPP Bureau - May 18, 2026

Antiviral injection addressing CMV and HSV infections had US market sales of nearly $15 million in the last 12 months

Women’s hospital opens in Delhi with $5 million backing
Women’s hospital opens in Delhi with $5 million backing

By IPP Bureau - May 18, 2026

30,000 sq. ft. multispeciality facility aims to deliver integrated care for women across every life stage

Mankind launches ‘Act at 30’ campaign to push early heart health screening
Mankind launches ‘Act at 30’ campaign to push early heart health screening

By IPP Bureau - May 18, 2026

Nationwide preventive health initiative aims to make cardiovascular screening at age 30 a standard healthcare milestone

Africa CDC warns of regional Ebola spread risk as DRC and Uganda confirm outbreaks
Africa CDC warns of regional Ebola spread risk as DRC and Uganda confirm outbreaks

By IPP Bureau - May 18, 2026

Africa CDC activates continental coordination measures; consultations underway on possible Public Health Emergency declaration

Dr Jitendra Singh commends SCTIMST doctors for treating  17,000 patients under AB-PMJAY
Dr Jitendra Singh commends SCTIMST doctors for treating 17,000 patients under AB-PMJAY

By IPP Bureau - May 18, 2026

At the institute's 42nd convocation ceremony, Union Minister described its eight-institution MoU initiative as a unique collaborative effort that brings together premier national institutions to create a synergistic research ecosystem

Experts calls for urgent preventive action as hypertension cases rise
Experts calls for urgent preventive action as hypertension cases rise

By IPP Bureau - May 18, 2026

Union Minister Prataprao Jadhav terms hypertension a “silent killer”; experts push for early screening, lifestyle correction and wellness-focused healthcare

Surya Hospitals expands advanced women-centric health services
Surya Hospitals expands advanced women-centric health services

By IPP Bureau - May 18, 2026

New facility ‘Amber Wing’ adds 55 beds and strengthens surgical, cardiac, robotic and preventive care infrastructure for women in Mumbai

WFNS opens doors to industry in landmark Neurosurgery Innovation Pact with Time Med
WFNS opens doors to industry in landmark Neurosurgery Innovation Pact with Time Med

By IPP Bureau - May 16, 2026

The move signals a strategic pivot toward deeper integration between clinical leadership and medical technology developers

Dr. Reddy’s launches generic semaglutide in Canada
Dr. Reddy’s launches generic semaglutide in Canada

By IPP Bureau - May 16, 2026

Dr. Reddy’s is the first company to receive Health Canada approval for generic Semaglutide Injection in Canada

Lupin receives USFDA nod for Famotidine injection
Lupin receives USFDA nod for Famotidine injection

By IPP Bureau - May 15, 2026

Famotidine Injection USP is a generic version of Pepcid injection to be manufactured at its Nagpur facility for the U.S. market

Indoco Remedies' Baddi plant gets EU GMP approval from Malta Medicines Authority
Indoco Remedies' Baddi plant gets EU GMP approval from Malta Medicines Authority

By IPP Bureau - May 15, 2026

The certification follows an inspection conducted by the Malta Medicines Authority between January 29, 2026, and February 3, 2026

Latest Stories

Interviews

Packaging